Our UHN programs and services are among the most advanced in the world. We have grouped our physicians, staff, services and resources into 10 medical programs to meet the needs of our patients and help us make the most of our resources.
University Health Network is a health care and medical research organization in Toronto, Ontario, Canada. The scope of research and complexity of cases at UHN has made us a national and international source for discovery, education and patient care.
Our 10 medical programs are spread across eight hospital sites – Princess Margaret, Toronto General, Toronto Rehab’s five sites, Toronto Western – as well as our education programs through the Michener Institute of Education at UHN. Learn more about the services, programs and amenities offered at each location.
Maps & Directions
Find out how to get to and around our nine locations — floor plans, parking, public transit, accessibility services, and shuttle information.
Ways You Can Help
Being touched by illness affects us in different ways. Many people want to give back to the community and help others. At UHN, we welcome your contribution and offer different ways you can help so you can find one that suits you.
The Newsroom is the source for media looking for information about UHN or trying to connect with one of our experts for an interview. It’s also the place to find UHN media policies and catch up on our news stories, videos, media releases, podcasts and more.
Air Date: November 2, 2022 | Length: 43:57 | Download the transcript
Share this episode:
Traumatic brain injuries are considered to be an invisible condition. We can't often see the effects and 50% of patients experience personality change, irritability, anxiety, and depression after concussion. Repeat traumatic brain injuries may increase your risk for a condition called Chronic Traumatic Encephalopathy.
Dr. Carmela Tartaglia's research looks to identify diagnostic tools to predict if an individual could develop CTE after sustaining repeat head injuries. Dr. Tartaglia's team is looking at implementing tools that target a protein called Tau, which is known to be elevated in CTE. In combination with other tests and screening methods, the hope is to be able to predict the progression of CTE, while implementing therapeutic strategies early on in the disease.
Dr. Carmela Tartaglia is a Clinician Scientist at Krembil Brain Institute, part of University Health Network (UHN), and The University of Toronto. She maintains a cognitive/behavioural clinic within the UHN Memory Clinic, where she sees patients with neurodegenerative diseases and persisting symptoms of concussion. As well, she is interested in the delayed effects of concussions. She holds the Marion and Gerald Soloway Chair in Brain Injury and Concussion Research and is one of the principle investigators at the Canadian Concussion Centre. The goal of her research program is to develop biomarkers for early detection of disease, so as to bring precision medicine and targeted, early treatments to her patients.